Ling Shi

589 total citations
24 papers, 365 citations indexed

About

Ling Shi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ling Shi has authored 24 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Ling Shi's work include RNA modifications and cancer (3 papers), Lipid metabolism and disorders (2 papers) and Cancer-related molecular mechanisms research (2 papers). Ling Shi is often cited by papers focused on RNA modifications and cancer (3 papers), Lipid metabolism and disorders (2 papers) and Cancer-related molecular mechanisms research (2 papers). Ling Shi collaborates with scholars based in China, United States and Hong Kong. Ling Shi's co-authors include Wenting Liao, JoAnn E. Manson, Frank B. Hu, Urban A. Kiernan, Qi Sun, Barbara B. Kahn, Kathryn M. Rexrode, David Phillips, Christine M. Albert and Jing Zhou and has published in prestigious journals such as Circulation, PLoS ONE and Cancer.

In The Last Decade

Ling Shi

24 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Shi China 9 221 85 50 49 48 24 365
Bushra Rahman United States 13 278 1.3× 58 0.7× 138 2.8× 14 0.3× 44 0.9× 24 527
Kosuke Tsukamoto Japan 10 237 1.1× 52 0.6× 129 2.6× 16 0.3× 23 0.5× 19 438
Yilin Wu China 11 191 0.9× 123 1.4× 61 1.2× 7 0.1× 52 1.1× 44 431
Young‐Joon Hong South Korea 11 244 1.1× 81 1.0× 79 1.6× 8 0.2× 25 0.5× 20 498
Qingqing Wang China 11 112 0.5× 38 0.4× 36 0.7× 11 0.2× 49 1.0× 27 296
Juhyung Woo United States 11 270 1.2× 113 1.3× 87 1.7× 13 0.3× 99 2.1× 26 507
Hillary Dinh United States 6 82 0.4× 27 0.3× 65 1.3× 15 0.3× 60 1.3× 11 462
Dongsheng Shang China 10 239 1.1× 116 1.4× 47 0.9× 9 0.2× 44 0.9× 16 387
Yuan Zhuang China 12 153 0.7× 50 0.6× 66 1.3× 17 0.3× 42 0.9× 43 366

Countries citing papers authored by Ling Shi

Since Specialization
Citations

This map shows the geographic impact of Ling Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Shi more than expected).

Fields of papers citing papers by Ling Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Shi. The network helps show where Ling Shi may publish in the future.

Co-authorship network of co-authors of Ling Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Shi. A scholar is included among the top collaborators of Ling Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Shi. Ling Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yun, Xuejie Han, Tao Feng, et al.. (2025). Gut-microbiota-derived indole sulfate promotes heart failure in chronic kidney disease. Cell Host & Microbe. 33(10). 1715–1730.e5. 2 indexed citations
2.
Shi, Ling, et al.. (2025). Oxidative stress in endometriosis: Sources, mechanisms and therapeutic potential of antioxidants (Review). International Journal of Molecular Medicine. 55(5). 1–11. 7 indexed citations
3.
Xiong, Qing, et al.. (2023). Mitochondrial genome diversity of Balamuthia mandrillaris revealed by a fatal case of granulomatous amoebic encephalitis. Frontiers in Microbiology. 14. 1162963–1162963. 3 indexed citations
4.
Wang, Lin, Ling Shi, Yonghao Liang, et al.. (2023). Dissecting the effects of METTL3 on alternative splicing in prostate cancer. Frontiers in Oncology. 13. 1227016–1227016. 5 indexed citations
5.
Shi, Ling, Xuexin Jin, Zheng Li, et al.. (2022). Mettl3 deficiency leads to the upregulation of Cav1.2 and increases arrhythmia susceptibility in mice. Acta Biochimica et Biophysica Sinica. 54(2). 199–208. 3 indexed citations
6.
Shi, Ling, et al.. (2022). Shipi Shugan Decoction Protected against Sequela of Pelvic Inflammatory Disease via Inhibiting SIRT1/NLRP3 Signaling Pathway in Pelvic Inflammatory Disease Rats. Evidence-based Complementary and Alternative Medicine. 2022. 1–13. 3 indexed citations
7.
Li, Xingda, Yang Zhang, Shihua Zhao, et al.. (2022). Cullin-associated and neddylation-dissociated 1 protein (CAND1) governs cardiac hypertrophy and heart failure partially through regulating calcineurin degradation. Pharmacological Research. 182. 106284–106284. 6 indexed citations
8.
Xie, Xiaoyu, et al.. (2021). Increased expression of microRNA-26a-5p predicted a poor survival outcome in osteosarcoma patients. Medicine. 100(12). e24765–e24765. 10 indexed citations
9.
Wang, Li, Huawei Zhu, Weiliang Sun, et al.. (2021). Low expression of bestrophin-2 is associated with poor prognosis in colon cancer. Gene. 813. 146117–146117. 1 indexed citations
11.
Li, Yao, et al.. (2020). Osthole attenuates pulmonary arterial hypertension by the regulation of sphingosine 1-phosphate in rats. Chinese Journal of Natural Medicines. 18(4). 308–320. 10 indexed citations
13.
14.
Li, Tao, et al.. (2015). Screening of differentially-expressed genes in the muscles of rabbit breeds with expression profile chip. Genetics and Molecular Research. 14(3). 8038–8045. 6 indexed citations
15.
Tan, Xiaoyu, et al.. (2014). EPHX1 Tyr113His and His139Arg polymorphisms in esophageal cancer risk: a meta-analysis. Genetics and Molecular Research. 13(1). 649–659. 6 indexed citations
16.
Shi, Ling, et al.. (2013). High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma. PLoS ONE. 8(6). e64709–e64709. 50 indexed citations
17.
Sun, Qi, Urban A. Kiernan, Ling Shi, et al.. (2013). Plasma Retinol-Binding Protein 4 (RBP4) Levels and Risk of Coronary Heart Disease. Circulation. 127(19). 1938–1947. 97 indexed citations
18.
Cooley, Mary E., Qian Wang, Kristin Röper, et al.. (2012). Health Behaviors, Readiness to Change, and Interest in Health Promotion Programs Among Smokers With Lung Cancer and Their Family Members. Cancer Nursing. 36(2). 145–154. 32 indexed citations
19.
Liao, Wenting, Xi Wang, Lihua Xu, et al.. (2009). Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival. Cancer. 115(7). 1507–1517. 57 indexed citations
20.
Shi, Ling, et al.. (2000). Effect of forskolin on acetylcholine-induced current in rat pheochromocytoma cells.. PubMed. 21(3). 281–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026